Tuesday, May 20, 2025 · SEC filings
What the smart money revealed on May 20
771 insider filings came in. We hid 60 planned (10b5-1) sellers and 491 people whose filings were routine, like grants and tax withholding.
4 insiders at Relmada Therapeutics (RLMD) bought $462K of stock
Roles: CEO, CFO, COO, CA and CO. Several insiders buying in the same few days is rare.
3 insiders at Greenidge Generation (GREE) bought $196K of stock
Roles: CEO, CFO, Director. Several insiders buying in the same few days is rare.
3 insiders at HCW Biologics (HCWB) bought $170K of stock
Roles: CEO, Director. Several insiders buying in the same few days is rare.
Biodesix (BDSX) Director Jack Schuler bought $1.33M
4.72M shares on the open market. Not a grant or an option exercise.
Smith Douglas Homes (SDHC) Director Thomas Bradbury bought $701K
36,300 shares on the open market. Not a grant or an option exercise.
Better Home & Finance Holding (BETR) Director Prabhu Narasimhan bought $597K
42,352 shares on the open market. Not a grant or an option exercise.
Claritev (CTEV) EVP Jerome Hogge bought $349K
12,500 shares on the open market. Not a grant or an option exercise.
Waystar Holding (WAY) Director Paul Moskowitz sold $130M
Not marked as a planned 10b5-1 sale. Sold 9% of the shares they held directly. Still holds 36.8M shares.
Loar (LOAR) Director David Abrams sold $56.9M
Not marked as a planned 10b5-1 sale. Sold 2% of the shares they held directly. Still holds 32.05M shares.
Quantum Computing (QUBT) Director Javad Shabani sold $466K
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 51 more real buys
Show 126 more real sales
13F season
Holdings as of Mar 31, 2025 were due May 15
92 funds have filed. 80 filed for the quarter before.
Biggest real insider buys, May 14–20
Open-market buys by officers and directors, filed in the 7 days up to May 20.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.